Advertisement

Topics

FDA approves first Suboxone generics for opioid dependence

05:03 EDT 13 Jul 2018 | Generics and Biosimilars Initiative

The US Food and Drug Administration (FDA) announced on 14 June 2018 that it had approved the first generics of Suboxone (buprenorphine/naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. The generics have been developed by Indian generics maker Dr Reddy’s Laboratories (Dr Reddy’s) and US-based drugmaker Mylan.

Original Article: FDA approves first Suboxone generics for opioid dependence

NEXT ARTICLE

More From BioPortfolio on "FDA approves first Suboxone generics for opioid dependence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...